SPHINGOLIPID MEDIATORS AND INTESTINAL TUMORIGENESIS

鞘脂介质和肠肿瘤发生

基本信息

  • 批准号:
    8248355
  • 负责人:
  • 金额:
    $ 32.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-12-01 至 2012-11-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY (See instructions): Sphingolipid mediators, are involved in complex cell signaling pathways that regulate cell growth, apoptosis and differentiation. Dietary sphingomyelin is avidly metabolized in the intestinal tract into polar metabolites such as sphingosine and sphingosine 1-phosphate (S1P). Our laboratory defined the first G protein-coupled receptor for SIP and characterized its receptor-dependent actions. Merrill and colleagues have shown that dietary sphingomyelin is chemopreventive in carcinogen-induced and tumor-suppressor gene deleted (ApcMin/+) models of intestinal tumorigenesis. In addition, increased intake of sphingolipid-rlch diets (such as soy), which raises intracellular sphingosine levels is associated with reduced Incidence of intestinal cancer. These data suggest that sphingolipid mediators are potent modulators of intestinal tumorigenesis. This proposal is based on the hypothesis that sphingosine kinase is a key regulatory enzyme that facilitates intestinal tumorigenesis by suppressing intracellular levels of tumor suppressor lipid sphingosine and enhancing pro-tumorigenic lipid mediator SIP. We propose to further define molecular mechanisms and test the biological significance in mouse models of intestinal cancer. Thus, the specific aims are: 1. To further define the role of sphingosine kinase enzymes in intestinal tumorigenesis. 2. To define the molecular mechanisms involved in the intracellular signaling of sphingosine, 3. We will test the hypothesis that increased intracellular sphingosine and reduced autocrine signaling of 81P brought about by gene deletion of Sphk enzymes is responsible for tumor suppressive action. Dietary sphingomyelin will be used to further Increase sphingosine levels in Sphk knockout mice and we will test whether this dietary manipulation further influences intestinal tumorigenesis in the ApcMin/-t- model. Since sphingolipid levels in the intestine can be altered by dietary means, this research promises to provide a novel means of cancer chemoprevention.
项目总结(见说明): 鞘脂介质参与调节细胞生长、凋亡和分化的复杂细胞信号传导途径。膳食鞘磷脂在肠道中被强烈代谢成极性代谢物,如鞘氨醇和鞘氨醇1-磷酸(S1 P)。我们的实验室确定了第一个G蛋白偶联受体SIP和其受体依赖性的行动。梅里尔及其同事 已经表明,膳食鞘磷脂在肠肿瘤发生的致癌物诱导和肿瘤抑制基因缺失(ApcMin/+)模型中具有化学预防作用。此外,增加鞘脂-rlch饮食(如大豆)的摄入量(其提高细胞内鞘氨醇水平)与肠癌发病率降低相关。这些数据表明,鞘脂介质是肠道肿瘤发生的有效调节剂。 这一建议是基于这样的假设,即鞘氨醇激酶是一种关键的调节酶,通过抑制细胞内水平的肿瘤抑制脂质鞘氨醇和增强促肿瘤发生脂质介体SIP来促进肠道肿瘤发生。我们建议在小鼠肠癌模型中进一步确定分子机制并测试生物学意义。因此,具体目标是: 1.进一步明确鞘氨醇激酶在肠道肿瘤发生中的作用。 2.为了确定鞘氨醇的细胞内信号传导所涉及的分子机制, 3.我们将测试的假设,增加细胞内鞘氨醇和减少自分泌信号的81 P所带来的基因缺失Sphk酶是负责肿瘤抑制作用。饮食鞘磷脂将用于进一步增加Sphk敲除小鼠中的鞘氨醇水平,并且我们将测试这种饮食操作是否进一步影响ApcMin/-t-模型中的肠肿瘤发生。 由于肠道中的鞘脂水平可以通过饮食方式改变,这项研究有望提供一种新的癌症化学预防方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Timothy Tun Hla其他文献

Timothy Tun Hla的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Timothy Tun Hla', 18)}}的其他基金

Myeloid sphingolipid regulation of tissue resolution and regeneration responses
骨髓鞘脂对组织分辨率和再生反应的调节
  • 批准号:
    10562518
  • 财政年份:
    2022
  • 资助金额:
    $ 32.96万
  • 项目类别:
Myeloid sphingolipid regulation of tissue resolution and regeneration responses
骨髓鞘脂对组织分辨率和再生反应的调节
  • 批准号:
    10708956
  • 财政年份:
    2022
  • 资助金额:
    $ 32.96万
  • 项目类别:
Sphingolipid signaling in age-associated vascular pathology
年龄相关血管病理学中的鞘脂信号传导
  • 批准号:
    10506516
  • 财政年份:
    2022
  • 资助金额:
    $ 32.96万
  • 项目类别:
G protein-coupled receptor regulation of transcriptional mechanisms in the retinal vasculature.
G 蛋白偶联受体对视网膜脉管系统转录机制的调节。
  • 批准号:
    10596099
  • 财政年份:
    2021
  • 资助金额:
    $ 32.96万
  • 项目类别:
G protein-coupled receptor regulation of transcriptional mechanisms in the retinal vasculature.
G 蛋白偶联受体对视网膜脉管系统转录机制的调节。
  • 批准号:
    10390409
  • 财政年份:
    2021
  • 资助金额:
    $ 32.96万
  • 项目类别:
G protein-coupled receptor regulation of transcriptional mechanisms in the retinal vasculature.
G 蛋白偶联受体对视网膜脉管系统转录机制的调节。
  • 批准号:
    10204421
  • 财政年份:
    2021
  • 资助金额:
    $ 32.96万
  • 项目类别:
Sphingolipid signaling in age-associated vascular pathology
年龄相关血管病理学中的鞘脂信号传导
  • 批准号:
    10253131
  • 财政年份:
    2020
  • 资助金额:
    $ 32.96万
  • 项目类别:
Mechanisms of sphingolipid signaling in vascular health and disease
血管健康和疾病中鞘脂信号传导的机制
  • 批准号:
    10536682
  • 财政年份:
    2017
  • 资助金额:
    $ 32.96万
  • 项目类别:
Mechanisms of sphingolipid signaling in vascular health and disease
血管健康和疾病中鞘脂信号传导的机制
  • 批准号:
    9244438
  • 财政年份:
    2017
  • 资助金额:
    $ 32.96万
  • 项目类别:
Mechanisms of sphingolipid signaling in vascular health and disease
血管健康和疾病中鞘脂信号传导的机制
  • 批准号:
    10091507
  • 财政年份:
    2017
  • 资助金额:
    $ 32.96万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 32.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 32.96万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 32.96万
  • 项目类别:
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 32.96万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 32.96万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 32.96万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 32.96万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 32.96万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 32.96万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 32.96万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了